# Understanding the Perioperative Perception of Pain in Patients with Crohn’s Disease: Epidural Versus Non-Epidural Analgesia

**Authors:** Regina Pistorius, Anna Widder, Marleen Sabisch, Christian Markus, Michael Meir, Imad Maatouk, Christoph-Thomas Germer, Patrick Meybohm, Nicolas Schlegel, Matthias Kelm, Sven Flemming

PMC · DOI: 10.3390/jcm14124383 · Journal of Clinical Medicine · 2025-06-19

## TL;DR

This study compares epidural and non-epidural pain management in Crohn’s disease patients after surgery, finding that epidural analgesia reduces early postoperative pain and opioid use.

## Contribution

The study provides new evidence on the effectiveness of epidural analgesia for postoperative pain in Crohn’s disease patients.

## Key findings

- Epidural analgesia significantly reduced early postoperative pain and analgesic consumption.
- Patients with epidural analgesia had a longer hospital stay and higher weak opioid use at discharge.
- No difference in pain perception was found between groups on day 5 post-surgery.

## Abstract

Background: Patients with Crohn’s disease (CD) suffer from a relevant burden of abdominal pain and psychological distress that can aggravate postoperatively. While systematic strategies for postoperative pain management are lacking, the potential benefit of perioperative epidural analgesia (EDA) in CD patients is unclear. Methods: All patients receiving an ileocecal resection due to CD at a tertiary hospital were included. The impact of epidural versus non-epidural analgesia on postoperative pain perception was evaluated by analyzing the numeric rating scale (NRS), analgesic consumption, and clinical outcomes. Results: In this monocentric study, 172 patients receiving ileocecal resection due to CD were included, with 122 receiving EDA. The epidural pain catheters were kept for an average of 4.4 days (±1.3) before being removed. EDA resulted in significantly decreased pain as well as a decreased amount of analgesic consumption (adjuvant analgesics: 16.4% vs. 32%, p = 0.021; strong opioids: 30.3% vs. 72.0%, p < 0.001) at the early postoperative course (1 vs. 3 at rest and 2 vs. 4 movement-evoked, p < 0.001). No difference in pain perception was detected on day 5 between EDA and non-EDA patients. Patients with EDA had a significantly longer length of hospital stay (7.5 versus 6 days, p = 0.002) and an increased intake of weak opioids at discharge (p = 0.024). Conclusions: While EDA in CD patients resulted in significantly decreased pain and decreased amounts of analgesic adjuvants and strong opioids at the early postoperative course, intravenous and oral analgesia provide sufficient postoperative pain control after surgery and earlier patient autonomy.

## Linked entities

- **Diseases:** Crohn’s disease (MONDO:0005011)

## Full-text entities

- **Diseases:** Pain (MESH:D010146), abdominal pain (MESH:D015746), CD (MESH:D003424), postoperative pain (MESH:D010149)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12193785/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12193785/full.md

## References

31 references — full list in the complete paper: https://tomesphere.com/paper/PMC12193785/full.md

---
Source: https://tomesphere.com/paper/PMC12193785